{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:58:29Z","timestamp":1793465909254,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the \"Pioneer\" and \"Leading Goose\" R&D Program of Zhejiang","award":["No. 2022C03145"],"award-info":[{"award-number":["No. 2022C03145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Alcoholism is a significant contributor to the development of alcoholic liver disease, for which no universally accepted and effective treatment currently exists. A precursor of <jats:bold>NAD<\/jats:bold>\n              <jats:sup>\n                <jats:bold>+<\/jats:bold>\n              <\/jats:sup>, \u03b2-Nicotinamide mononucleotide (NMN), has revealed potential therapeutic benefits. However, its effectiveness in preventing ethanol-induced liver damage remains uncertain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The objective of this study was to assess the protective effects of NMN and elucidate its potential mechanisms using a mouse model subjected to chronic and binge ethanol feeding. Eight-week-old C57BL\/6J mice were randomly assigned to one of four groups (<jats:italic>n<\/jats:italic>\u2009=\u200910 per group): control (CTRL), ethanol (EtOH), ethanol with low-dose NMN (EtOH\u2009+\u2009NMN(L)), and ethanol with high-dose NMN (EtOH\u2009+\u2009NMN(H)). Following the completion of the experimental protocol, the mice were euthanized at designated time points, and blood, liver, and ileum tissues were collected for analysis of relevant biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to the CTRL group, the EtOH group demonstrated increased liver specific gravity and elevated blood ALT levels. Administration of NMN improved histopathological changes in the liver and ileum of the mice. NMN significantly counteracted the ethanol-induced elevation in liver MDA levels and restored the diminished glutathione (GSH) and superoxide dismutase (SOD) activity levels caused by ethanol exposure. Additionally, NMN inhibited the ethanol-induced expression of cytochrome P450 2E1 (CYP2E1). It also reduced the release of pro-inflammatory cytokines, including TNF-\u03b1, IL-6, and IL-1\u03b2, which were triggered by ethanol exposure, improved energy homeostasis in the ileum, and reversed the downregulation of mRNA and protein expression of key tight junction proteins in the ileum, specifically ZO-1, Claudin-1, and Occludin, thereby restoring their functional integrity. Furthermore, NMN activated the <jats:bold>NAD<\/jats:bold>\n              <jats:sup>\n                <jats:bold>+<\/jats:bold>\n              <\/jats:sup>\/ <jats:bold>SIRT1<\/jats:bold> signaling pathway, leading to the upregulation of all target genes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>NMN supplementation provides protection against alcoholic liver injury in a mouse model, potentially through the upregulation of the cellular <jats:bold>NAD<\/jats:bold>\n              <jats:sup>\n                <jats:bold>+<\/jats:bold>\n              <\/jats:sup>\/ <jats:bold>SIRT1<\/jats:bold> pathway. This upregulation enhances antioxidant and anti-inflammatory activities and improves intestinal permeability.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00529-x","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T06:03:43Z","timestamp":1755324223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u03b2-Nicotinamide mononucleotide alleviates Alcohol-Induced liver injury in a mouse model through activation of NAD+\/SIRT1 signaling pathways"],"prefix":"10.1186","volume":"162","author":[{"given":"Xinxin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"529_CR1","doi-asserted-by":"publisher","unstructured":"Lim SS, Vos T, Flaxman AD et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010 [published correction appears in Lancet. 2013;381(9874):1276] [published correction appears in Lancet. 2013;381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added]]. Lancet. 2012;380(9859):2224\u20132260. https:\/\/doi.org\/10.1016\/S0140-6736(12)61766-8","DOI":"10.1016\/S0140-6736(12)61766-8"},{"issue":"47","key":"529_CR2","doi-asserted-by":"publisher","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","volume":"20","author":"E Ceni","year":"2014","unstructured":"Ceni E, Mello T, Galli A. Pathogenesis of alcoholic liver disease: role of oxidative metabolism. World J Gastroenterol. 2014;20(47):17756\u201372. https:\/\/doi.org\/10.3748\/wjg.v20.i47.17756.","journal-title":"World J Gastroenterol"},{"issue":"26","key":"529_CR3","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.3748\/wjg.v24.i26.2785","volume":"24","author":"CA Marroni","year":"2018","unstructured":"Marroni CA, Fleck AM Jr, Fernandes SA, et al. Liver transplantation and alcoholic liver disease: history, controversies, and considerations. World J Gastroenterol. 2018;24(26):2785\u2013805. https:\/\/doi.org\/10.3748\/wjg.v24.i26.2785.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"529_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12876-019-1050-9","volume":"19","author":"L Chuncharunee","year":"2019","unstructured":"Chuncharunee L, Yamashiki N, Thakkinstian A, Sobhonslidsuk A. Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19(1):150. https:\/\/doi.org\/10.1186\/s12876-019-1050-9. Published 2019 Aug 22.","journal-title":"BMC Gastroenterol"},{"issue":"39","key":"529_CR5","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.3748\/wjg.v16.i39.4905","volume":"16","author":"M Amini","year":"2010","unstructured":"Amini M, Runyon BA. Alcoholic hepatitis 2010: a clinician\u2019s guide to diagnosis and therapy. World J Gastroenterol. 2010;16(39):4905\u201312. https:\/\/doi.org\/10.3748\/wjg.v16.i39.4905.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"529_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","volume":"50","author":"A Keshavarzian","year":"2009","unstructured":"Keshavarzian A, Farhadi A, Forsyth CB, et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009;50(3):538\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2008.10.028.","journal-title":"J Hepatol"},{"key":"529_CR7","doi-asserted-by":"publisher","unstructured":"Poddar SK, Sifat AE, Haque S, Nahid NA, Chowdhury S, Mehedi I. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule. Biomolecules. 2019;9(1):34. Published 2019 Jan 21. https:\/\/doi.org\/10.3390\/biom9010034","DOI":"10.3390\/biom9010034"},{"key":"529_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fcell.2020.00246","volume":"8","author":"W Hong","year":"2020","unstructured":"Hong W, Mo F, Zhang Z, Huang M, Wei X, Nicotinamide Mononucleotide. A promising molecule for therapy of diverse diseases by targeting NAD+ metabolism. Front Cell Dev Biol. 2020;8:246. https:\/\/doi.org\/10.3389\/fcell.2020.00246. Published 2020 Apr 28.","journal-title":"Front Cell Dev Biol"},{"issue":"6158","key":"529_CR9","doi-asserted-by":"publisher","first-page":"1243417","DOI":"10.1126\/science.1243417","volume":"342","author":"CB Peek","year":"2013","unstructured":"Peek CB, Affinati AH, Ramsey KM, et al. Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science. 2013;342(6158):1243417. https:\/\/doi.org\/10.1126\/science.1243417.","journal-title":"Science"},{"issue":"1","key":"529_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40246-019-0251-1","volume":"13","author":"MA Assiri","year":"2019","unstructured":"Assiri MA, Ali HR, Marentette JO, et al. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Hum Genomics. 2019;13(1):65. https:\/\/doi.org\/10.1186\/s40246-019-0251-1. Published 2019 Dec 10.","journal-title":"Hum Genomics"},{"key":"529_CR11","doi-asserted-by":"publisher","unstructured":"Li W, Zhou Y, Pang N et al. NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial Function. Nutrients. 2022;15(1):174. Published 2022 Dec 30. https:\/\/doi.org\/10.3390\/nu15010174","DOI":"10.3390\/nu15010174"},{"key":"529_CR12","doi-asserted-by":"publisher","first-page":"112060","DOI":"10.1016\/j.fct.2021.112060","volume":"150","author":"C Cros","year":"2021","unstructured":"Cros C, Cannelle H, Laganier L, Grozio A, Canault M. Safety evaluation after acute and sub-chronic oral administration of high purity nicotinamide mononucleotide (NMN-C\u00ae) in Sprague-Dawley rats. Food Chem Toxicol. 2021;150:112060. https:\/\/doi.org\/10.1016\/j.fct.2021.112060.","journal-title":"Food Chem Toxicol"},{"issue":"6","key":"529_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills KF, Yoshida S, Stein LR, et al. Long-Term administration of nicotinamide mononucleotide mitigates Age-Associated physiological decline in mice. Cell Metab. 2016;24(6):795\u2013806. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.013.","journal-title":"Cell Metab"},{"issue":"3","key":"529_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013;8(3):627\u201337. https:\/\/doi.org\/10.1038\/nprot.2013.032.","journal-title":"Nat Protoc"},{"issue":"1","key":"529_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Cant\u00f3","year":"2015","unstructured":"Cant\u00f3 C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: A balancing act between mitochondria and the nucleus. Cell Metab. 2015;22(1):31\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.023.","journal-title":"Cell Metab"},{"issue":"3","key":"529_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","volume":"27","author":"L Rajman","year":"2018","unstructured":"Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-Boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2018.02.011.","journal-title":"Cell Metab"},{"key":"529_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.nutr.20.1.395","volume":"20","author":"CS Lieber","year":"2000","unstructured":"Lieber CS. ALCOHOL: its metabolism and interaction with nutrients. Annu Rev Nutr. 2000;20:395\u2013430. https:\/\/doi.org\/10.1146\/annurev.nutr.20.1.395.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"529_CR18","doi-asserted-by":"publisher","first-page":"e0212523","DOI":"10.1371\/journal.pone.0212523","volume":"14","author":"X Xiong","year":"2019","unstructured":"Xiong X, Yu J, Fan R, et al. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. PLoS ONE. 2019;14(2):e0212523. https:\/\/doi.org\/10.1371\/journal.pone.0212523. Published 2019 Feb 22.","journal-title":"PLoS ONE"},{"issue":"1","key":"529_CR19","doi-asserted-by":"publisher","first-page":"BSR20211005","DOI":"10.1042\/BSR20211005","volume":"42","author":"T Wang","year":"2022","unstructured":"Wang T, Zhang F, Peng W, et al. Overexpression of NMNAT3 improves mitochondrial function and enhances antioxidative stress capacity of bone marrow mesenchymal stem cells via the NAD+-Sirt3 pathway. Biosci Rep. 2022;42(1):BSR20211005. https:\/\/doi.org\/10.1042\/BSR20211005.","journal-title":"Biosci Rep"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"116799","DOI":"10.1016\/j.taap.2023.116799","volume":"482","author":"F Cheng","year":"2024","unstructured":"Cheng F, Zhang Y, Xiong H, et al. NMNATs expression Inhibition mediated NAD+ deficiency plays a critical role in doxorubicin-induced hepatotoxicity in mice. Toxicol Appl Pharmacol. 2024;482:116799. https:\/\/doi.org\/10.1016\/j.taap.2023.116799.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"529_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3978\/j.issn.2304-3881.2014.12.06","volume":"4","author":"M You","year":"2015","unstructured":"You M, Jogasuria A, Taylor C, Wu J. Sirtuin 1 signaling and alcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2015;4(2):88\u2013100. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.12.06.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"529_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/j.gastro.2013.11.008","volume":"146","author":"H Yin","year":"2014","unstructured":"Yin H, Hu M, Liang X, et al. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology. 2014;146(3):801\u201311. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.008.","journal-title":"Gastroenterology"},{"issue":"1","key":"529_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbrc.2008.03.005","volume":"370","author":"CS Lieber","year":"2008","unstructured":"Lieber CS, Leo MA, Wang X, Decarli LM. Effect of chronic alcohol consumption on hepatic SIRT1 and PGC-1alpha in rats. Biochem Biophys Res Commun. 2008;370(1):44\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2008.03.005.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"529_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3748\/wjg.v22.i1.50","volume":"22","author":"A Boye","year":"2016","unstructured":"Boye A, Zou YH, Yang Y. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: allies or enemies? World J Gastroenterol. 2016;22(1):50\u201371. https:\/\/doi.org\/10.3748\/wjg.v22.i1.50.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"529_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/13880209.2018.1517185","volume":"56","author":"HY Zhang","year":"2018","unstructured":"Zhang HY, Wang HL, Zhong GY, Zhu JX. Molecular mechanism and research progress on Pharmacology of traditional Chinese medicine in liver injury. Pharm Biol. 2018;56(1):594\u2013611. https:\/\/doi.org\/10.1080\/13880209.2018.1517185.","journal-title":"Pharm Biol"},{"key":"529_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/wjtcm.wjtcm_34_23","volume":"10","author":"YY Tan","year":"2024","unstructured":"Tan YY, Liu YY, Zhai YY, Wang YX, Wu ZS, Stalin A, Cheng GL, Li B, Wu C, Huang ZH, Lu S, Fan XT, Zhao Z, Wu JR. Investigating the potential mechanism of Huazhi Rougan granules against alcoholic liver disease by network Pharmacology and experiment. World J Tradit Chin Med. 2024;10:191\u2013203. https:\/\/doi.org\/10.4103\/wjtcm.wjtcm_34_23.","journal-title":"World J Tradit Chin Med"},{"key":"529_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","volume":"68","author":"L Yang","year":"2014","unstructured":"Yang L, Rozenfeld R, Wu D, Devi LA, Zhang Z, Cederbaum A. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including Inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med. 2014;68:260\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.12.026.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"529_CR28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1242\/dmm.012195","volume":"6","author":"O Tsedensodnom","year":"2013","unstructured":"Tsedensodnom O, Vacaru AM, Howarth DL, Yin C, Sadler KC. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Dis Model Mech. 2013;6(5):1213\u201326. https:\/\/doi.org\/10.1242\/dmm.012195.","journal-title":"Dis Model Mech"},{"issue":"3","key":"529_CR29","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.24766","volume":"55","author":"S Liu","year":"2012","unstructured":"Liu S, Yeh TH, Singh VP, et al. \u03b2-catenin is essential for ethanol metabolism and protection against alcohol-mediated liver steatosis in mice. Hepatology. 2012;55(3):931\u201340. https:\/\/doi.org\/10.1002\/hep.24766.","journal-title":"Hepatology"},{"issue":"4","key":"529_CR30","first-page":"277","volume":"27","author":"D Wu","year":"2003","unstructured":"Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health. 2003;27(4):277\u201384.","journal-title":"Alcohol Res Health"},{"issue":"2","key":"529_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jep.2010.01.029","volume":"128","author":"W Bao","year":"2010","unstructured":"Bao W, Li K, Rong S, et al. Curcumin alleviates ethanol-induced hepatocytes oxidative damage involving Heme oxygenase-1 induction. J Ethnopharmacol. 2010;128(2):549\u201353. https:\/\/doi.org\/10.1016\/j.jep.2010.01.029.","journal-title":"J Ethnopharmacol"},{"key":"529_CR32","doi-asserted-by":"crossref","unstructured":"Glade MJ, Meguid MM. A Glance At \u2026 ethanol consumption, GSH suppression, and oxidative liver damage. Nutrition. 2017;33:199\u2013203. doi:10.1016\/j.nut.2016.07.003.","DOI":"10.1016\/j.nut.2016.07.003"},{"issue":"5","key":"529_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7150\/ijbs.11039","volume":"11","author":"J Liu","year":"2015","unstructured":"Liu J, Wang X, Peng Z, et al. The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation. Int J Biol Sci. 2015;11(5):569\u201386. https:\/\/doi.org\/10.7150\/ijbs.11039. Published 2015 Apr 3.","journal-title":"Int J Biol Sci"},{"key":"529_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.redox.2014.07.007","volume":"2","author":"MA Barnes","year":"2014","unstructured":"Barnes MA, Roychowdhury S, Nagy LE. Innate immunity and cell death in alcoholic liver disease: role of cytochrome P4502E1. Redox Biol. 2014;2:929\u201335. https:\/\/doi.org\/10.1016\/j.redox.2014.07.007. Published 2014 Aug 1.","journal-title":"Redox Biol"},{"key":"529_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.biopha.2018.01.079","volume":"99","author":"R Yuan","year":"2018","unstructured":"Yuan R, Tao X, Liang S, et al. Protective effect of acidic polysaccharide from schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. Biomed Pharmacother. 2018;99:537\u201342. https:\/\/doi.org\/10.1016\/j.biopha.2018.01.079.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"529_CR36","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/acer.13078","volume":"40","author":"S Wang","year":"2016","unstructured":"Wang S, Pacher P, De Lisle RC, Huang H, Ding WX. A mechanistic review of cell death in Alcohol-Induced liver injury. Alcohol Clin Exp Res. 2016;40(6):1215\u201323. https:\/\/doi.org\/10.1111\/acer.13078.","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"529_CR37","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/CS20140576","volume":"128","author":"DH Lee","year":"2015","unstructured":"Lee DH, Kim DH, Hwang CJ, et al. Interleukin-32\u03b3 attenuates ethanol-induced liver injury by the Inhibition of cytochrome P450 2E1 expression and inflammatory responses. Clin Sci (Lond). 2015;128(10):695\u2013706. https:\/\/doi.org\/10.1042\/CS20140576.","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"529_CR38","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1111\/acer.14176","volume":"43","author":"DR Samuelson","year":"2019","unstructured":"Samuelson DR, Gu M, Shellito JE, et al. Intestinal microbial products from Alcohol-Fed mice contribute to intestinal permeability and peripheral immune activation. Alcohol Clin Exp Res. 2019;43(10):2122\u201333. https:\/\/doi.org\/10.1111\/acer.14176.","journal-title":"Alcohol Clin Exp Res"},{"key":"529_CR39","doi-asserted-by":"publisher","first-page":"710381","DOI":"10.1155\/2010\/710381","volume":"2010","author":"J Petrasek","year":"2010","unstructured":"Petrasek J, Mandrekar P, Szabo G. Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract. 2010;2010:710381. https:\/\/doi.org\/10.1155\/2010\/710381.","journal-title":"Gastroenterol Res Pract"},{"key":"529_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.biopha.2019.01.007","volume":"111","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Qu W, Wang K, et al. Bisphenol A inhibits mucin 2 secretion in intestinal goblet cells through mitochondrial dysfunction and oxidative stress. Biomed Pharmacother. 2019;111:901\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2019.01.007.","journal-title":"Biomed Pharmacother"},{"issue":"6351","key":"529_CR41","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","volume":"357","author":"MX Byndloss","year":"2017","unstructured":"Byndloss MX, Olsan EE, Rivera-Ch\u00e1vez F, et al. Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357(6351):570\u20135. https:\/\/doi.org\/10.1126\/science.aam9949.","journal-title":"Science"},{"key":"529_CR42","doi-asserted-by":"publisher","first-page":"714604","DOI":"10.3389\/fnut.2021.714604","volume":"8","author":"P Huang","year":"2021","unstructured":"Huang P, Jiang A, Wang X, et al. NMN maintains intestinal homeostasis by regulating the gut microbiota. Front Nutr. 2021;8:714604. https:\/\/doi.org\/10.3389\/fnut.2021.714604. Published 2021 Jul 29.","journal-title":"Front Nutr"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00529-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T18:02:53Z","timestamp":1755367373000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00529-x","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the experimental Animal Ethics Committee of Wenzhou Medical University(Approval number is wydw2023-0373). All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}